Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human minibody against complement component C5

EU orphan designation number: EU/3/11/926   
Active ingredient: Recombinant human minibody against complement component C5
Indication: Treatment of primary membranoproliferative glomerulonephritis
Sponsor: ADIENNE S.r.l.
Via Galileo Galilei 19, 20867 Caponago (MB), Italia

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/10/2011 Centralised Orphan - Designation EMA/OD/053/11 (2011)7903 of 27/10/2011
18/01/2012 Corrigendum (2011)7903 of 13/01/2012
15/01/2014 Centralised Orphan - Change of address